期刊文献+

verteporfin光动力疗法对体外培养的成人视网膜色素上皮细胞色素上皮衍生因子、血管内皮生长因子表达水平的影响 被引量:2

Influence of photodynamic therapy on expression of pigment epithelial derivative factor and vascular endothelial growth factor in adult human retinal pigment epithelial cells
原文传递
导出
摘要 目的观察经光敏剂verteporfin光动力疗法(PDT)处理后的体外培养的成人视网膜色素上皮(RPE)细胞色素上皮衍生因子(PEDF)、血管内皮生长因子(VEGF)mRNA表达水平的改变。方法采用噻唑蓝比色法(MTT)测定PDT前后体外培养的成人RPE细胞活性的变化。应用半定量逆转录聚合酶链式反应(RT-PCR)测定PDT前后RPE细胞PEDF和VEGFmRNA表达水平的变化。结果PDT可造成RPE细胞死亡,死亡率与激光能量密度和光敏剂浓度成正相关。PDT后RPE细胞表达PEDF、VEGFmRNA水平下降,下降程度与激光能量密度和光敏剂浓度成正相关。结论PDT可下调体外培养的成人RPE细胞PEDF、VEGFmRNA的表达水平,这可能与PDT治疗黄斑下脉络膜新生血管膜(CNVM)后CNVM的消退或再生有关。 Objective To investigate the impact of photodynamic therapy (PDT) with verteporfin on the expression of pigment epithelial derivative factor (PEDF) mRNA and vascular endothelial growth factor (VEGF) mRNA in adult retinal pigment epithelial (RPE) cells in vitro. Methods The changes of cellular viability before and after PDT were assessed by methyl thiazolyl tetrazolum (MTT) colorimetric assay. Semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) was conducted to detect the expression of PEDF and VEGF mRNA in RPE cells before and after PDT. Results PDT caused the death of RPE cells. The cellular mortality was positively correlated with the power of photocoagulation and the concentration of verteporfin. Conclusion PDT could down-regulate the expression of PEDF and VEGF mRNA in adult RPE cells in vitro, which may relate to the cure or relapse of subfoveal choroidal neovascular membrane after PDT.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2006年第4期256-260,共5页 Chinese Journal of Ocular Fundus Diseases
基金 国家教委留学回国人员启动基金(H-15)
关键词 光疗法 视网膜色素上皮 内皮 血管 生长物质 细胞培养 Phototherapy Retinal pigment epithelium of eye Endothelium, vascular Growth sabstances Cell culture
  • 相关文献

参考文献15

  • 1Jennifer IL.Age-related Macular Degeneration.New York:Marcel Dekker Inc,2002.15-25.
  • 2Ohno-Matsui K,Morita I,Tombran-Tink J,et al.Novel mechanism for age-related macular degeneration:an equilibrium shift between the angiogenesis factors VEGF and PEDF.J Cell Physiol,2001,189:323-333.
  • 3Ohno-Matsui K,Yoshida T,Uetama T,et al.Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.Biochem Biophys Res Commun,2003,303:962-967.
  • 4Gouras P,Lopez R.Transplantation of retinal epithelial cells.Invest Ophthalmol Vis Sci,1989,30:1681-1683.
  • 5Haimovici R,Kramer M,Miller JW,et al.Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye.Curr Eye Res,1997,16:83-90.
  • 6Huang Y,Obana A,Gohto Y,et al.Comparative study of the phototoxicity of two chrolin type photosensitizers,ATX-S10(Na)and Verteporfin,on vascular endothelial and retinal pigment epithelial cells.Lasers Surg Med,2004,34:216-226.
  • 7Zacks DN,Ezra E,Terada Y,et al.Verteporfin photodynamic therapy in the rat model of ehoroidal neovascularization:angiographic and histologic characterization.Invest Ophthalmol Vis Sci,2002,43:2384-2391.
  • 8Wachtlin J,Behme T,Heimann H,et al.Concentric retinal pigment epithelium atrophy after a single photodynamic therapy.Graefe's Arch Clin Exp Ophthalmol,2003,241:518-521.
  • 9Postelmans L,Pasteels B,Coquelet P,et al.Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females.Am J Ophthalmol,2004,138:803-808.
  • 10Schmidt-Erfurth U,Laqua H,Schlotzer-Schrehard U,et al.Histopathological changes following photodynamic therapy in human eyes.Arch Ophthalmol,2002,120:835-844.

同被引文献25

  • 1张力,赵明威,黎晓新,姜燕荣,吕永顺.影响光动力疗法治疗脉络膜新生血管视力预后的多因素分析[J].中华眼底病杂志,2004,20(5):292-294. 被引量:19
  • 2都镇先,张海燕,尹福在,杨向红,刘国良.血管内皮生长因子反义寡核苷酸在人甲状腺髓样癌裸鼠模型中的抑瘤作用[J].中华肿瘤防治杂志,2006,13(19):1452-1456. 被引量:4
  • 3Dougherty T J, Gomer C J, Henderson B W, et al. Photodynamic therapy. J Natl Cancer Inst, 1998, 90.. 889-905.
  • 4Jarvi M T, Niedre M J, Patterson M S, et al. Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy.. current status, challenges and future prospects. Photochem Photohiol, 2006, 82: 1198-1210.
  • 5Castano A P, Demidova T N, Hamblin M R. Mechanisms in photodynamic therapy. Part Photose-nsitizers, photoehenistry and cellular localization. Photodiagnos Photodynam Ther, 2004, 1: 279-293.
  • 6Ash D V, Brown S B. New drugs and future developments in photodynamie therapy. Eur J Cancer, 1993, 29A: 1781-1783.
  • 7Kessel D, Woodburn K. Biodistribution of photosensitizing agents. Int J Biochem, 1993, 25: 1377-1383.
  • 8Service R F. Materials and biology. Nanotechnology takes aim at cancer. Science, 2005, 310: 1132-1134.
  • 9Campoehiaro P A, Soloway P, Ryan S J, et al. The pathogenesis of choroidal neovascularization in patients with age-related maeular degeneration. Mol Vis, 1999, 5:34.
  • 10Grossniklaus H E, Green W R. Choroidal neovascularization. Am J Ophthalmol, 2004, 137: 496-503.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部